Article / 23 August 2016 at 2:54 GMT

Morning Report APAC: Wheeler keeps shots in locker

APAC Sales Trading Desk / Saxo Capital Markets


  • RBNZ chief Graeme Wheeler plans to keep his powder dry after latest cut
  • USD's continued slide helped rise in NZD
  • All markets waiting for outcome of Janet Yellen and Jackson Hole


By Saxo APAC Sales Trading

Economic data of the day (Singapore Time; GMT+8)


– 12:00: JPY: Kuroda speaks at BoJ’S fintech conference
– 18:30: EUR: ECB’s Coeure Lane, Smets on panel in Geneva

Overnight news

New Zealand

New Zealand central banker Graeme Wheeler said that while he intends to lower interest rates further to revive inflation, a series of rapid cuts is not justified:

  • We do not believe the outlook and balance of risks warrants a position of no policy change, nor a position of rapid easings.
  • Rapid ongoing decreases in interest rates would likely result in an unsustainable surge in growth and capacity bottlenecks, and further inflame an overheating property market.
  • Low headline inflation could bring down inflation expectations in a self-perpetuating spiral that would be hard to correct, the main reason for the decision to ease rates this month.
  • Cutting rates too quickly “would use up much of the bank’s capacity to respond to the likely boom-bust situation that would follow and place the Reserve Bank in a situation similar to many other central banks of having limited room to respond to economic or financial shocks.


  • Chicago Fed National Activity Index rose to +0.27 (Mkt est: +0.20) from +0.05 in June. The sales, orders and inventories category inched up to +0.01 from -0.01. The contribution of the personal consumption and housing category was steady at -0.06. A barometer of national economic activity, it improved to a year high in July.

Foreign exchangex


  • Hawkish Fed speeches didn’t work and USD sold off overnight against most currencies.
  • The biggest mover was NZD, which rallied almost 1% helped by USD selling and Wheeler comments saying RBNZ is not in a rush to cut further.
  • In emerging markets, there was also some lesser USD selling following Short USD stops in EM currencies. The market is now waiting on Jackson Hole from Friday night.

Foreign exchange movementsx

  •  There is a lot of buy interest in short-dated USD Calls (Monday) in case Janet Yellen’s speech at the weekend holds surprises. The interests are in AUD, EUR and USDJPY.
  • Hedge funds are also buying the next BoJ date in USDJPY at the market (ATM).
  • In emerging markets, the rally in long-dated forward points in USDCNH is triggering buying interest in 1-year volatility.
  • 1-year ATM moved from 6.3 to 6.8 in four sessions but is still below long-time support of 7 volatilities.



  • US benchmark yields declined across maturities as oil prices slipped and equities fluctuated, 10-year note yields falling most in more than a week.
  • Market pricing of the Fed funds rate firmed slightly, implying about a 25% chance of a rate hike in September, a 65% chance by December and 100% by August 2017.
  • Benchmark German 10-year bunds advanced on Monday with euro-area counterparts after sliding last week. JPMorgan enter shorts in 10Y Germany; turn bearish on duration into September with yields close to record lows, risks of ECB resumption in supply; reduced exposure to periphery tighteners.
  • Yield on 10-year JGB rises 2bp to -0.070% on position adjustment ahead of 20-year bonds auction.
  • Following the Wheeler comments, market is pricing in only 29.4% chance of cut by RBNZ for September and 68.4% chance in November, mainly for a 25bp cut.






  • S&P 500 and DJI logged losses as energy sector was hit by oil price declines, while Nasdaq bucked the trend to eke out a gain as investors Jackson Hole.
  • Pfizer (-0.4%) confirmed its plan to buy biotech Medivation (+19.7%) for about $14 billion cash to expand its line-up of oncology treatments at $81.50 a share, a 21% premium on Medivation’s Friday close.
  • Valeant Pharmaceuticals International surged 8.8% after confirming it has hired a new chief financial officer.
  • European stocks inched higher as strength in healthcare and financials overcame energy sector weakness.
  • Syngenta surged 10.6% after the US Committee on Foreign Investment cleared China National Chemical’s $43 billion takeover bid.
  • Teleperformance leapt 8.9% as the outsourcing company said it is buying translation services company LanguageLine Solutions in a $1.52 billion deal.

Asia-Pacific stocks

Hong Kong
Analyst ratings

- Anhui Conch (914 HK): Raised to hold at Jefferies

- Guangzhou Yuexiu (000987 CH): Rated new buy at Northeast Sec

- Kingsoft (3888 HK): Raised to outperform at Credit Suisse

- Huatai Securities (601688 CH): Raised to buy at Northeast Sec

- Sinopec Engineering (2386 HK): Cut to neutral at Nomura

- Sinopharm (1099 HK): Cut to neutral at Credit Suisse

- Wuhan Dept Store (000501 CH): Rated new add at Northeast Sec


- HK&CH Gas (3) 1H net profit HK$4.33bn, +3% YoY. Sales HK$14.2bn

- K Wah (173)’s Lui Che-woo said he hopes government will relax housing measures to enable citizens to change flats
- Vanke (2202) said there were 31 projects postponed or cancelled Jun-Aug due to ownership raid

- CK PPTY (1113) is said to sell its 75% stake in The Center at HK$34.8b

- Wanda (3699) seeks to extend $500m loan and a waiver for delisting and having breached a financial covenant

- Chong Hing BK (1111) 1H net profit HK$592m, -18.5% YoY

- Central CH Sec (1375) 1H net profit RMB306mln, rev RMB1.5bn

- CH National Buildg Material (3323) said restructuring with the parent co. has been approved

- Anhui Conch (914) net profit RMB3.36b, -29% YoY. Rev RMB24b, -1.03% YoY

- Tianrui (1252) 1H net profit RMB178.1mln, -27.5% YoY. Rev RMB3.1b, -10.9% YoY

- CRRC (1766) 1H net profit RMB4.79bn, +2% YoY. Rev RMB92.3bn, +0.55% YoY

- Sinopec Eng (2386) says it may win refining contract in Iran in 2H. Its FY target of new contracts is RMB46bn

-      Modern Dairy (1117) 1H net loss RMB565.7mln vs RMB477mln profit yr ago. Rev RMB2.23bn, -8.6% YoY

-      Dah Chong Hong (1828) 1H net profit HK$220m, -21.4% YoY

-      Zhengtong Auto (1728) 1H net profit RMB253mln, -26.98% YoY. Rev RMB14.5bn, +5.23% YoY. Car sales 44.5k units, +10.8% YoY, of which luxury brands 31.5k units, +14.2% YoY

Analyst ratings

- Hoshizaki (6465 JP): Cut to neutral at Tokai Tokyo

- Nippon Paper (3863 JP): Resumed at underweight at Mitsubishi UFJ Morgan Stanley

- Nissin Foods (2897 JP): Raised to overweight from underweight at JPMorgan

- Tokyo Gas (9531 JP): Raised to buy at Daiwa
- Tokyu (9005 JP): Raised to buy at Okasan
Analyst ratings

- Japara Healthcare (JHC@AU) cut to underweight v equalweight at Morgan Stanley

- Primary Health (PRY@AU) cut to underweight v equalweight at Morgan Stanley

- IAG (IAG@AU) cut to sell v hold at Shaw & Partners

- NIB Holdings (NHF@AU) cut to underperform at Credit Suisse

- Automotive Holdings (AHG@AU) cut to hold at Bell Potter

- Infigen (IFN@AU) raised to buy at Canaccord Genuity


- Synlait Milk (SML@NZ), A2 Milk (ATM@NZ) reaffirm infant formula supply arrangements

- Mercury (MCY@NZ) full-year underlying earnings rise 2.3% to NZ$493mln

- NZ Refining (NZR@NZ) first-half net profit falls 82% YoY to NZ$11.1mln

- Tourism Holdings (THL@NZ) full-year net profit NZ$24.4mln

- Comvita (CVT@NZ) full-year earnings

- Aconex (ACX@AU) full-year earnings

- Monadelphous (MND@AU) full-year earnings

- Greencross (GXL@AU) full-year earnings

- Virtus Health (VRT@AU) full-year earnings

- Caltex (CTX@AU) first-half earnings

- Scentre Group (SCG@1H) first-half earnings

- Oil Search (OSH@1H) first-half earnings

- Vocus (VOC@AU) full-year earnings

- Healthscope (HSO@AU) full-year earnings

- Blackmores (BKL@AU) full-year earnings

- Fisher & Paykel Healthcare (FPH@NZ) annual meeting

- Macquarie (MQG@AU) CEO Nicholas Moore speaks at British Chamber of Commerce

- AGL (AGL@AU) CEO Andrew Vesey speaks at CEDA event, Melbourne
Source: CIMB / Bloomberg


The ball is firmly back in RBNZ's Graeme Wheeler's court after he dampens
the outlook for more cuts. Photo: iStock

– Edited by John Hampshire

This report was compiled by the Saxo APAC Sales trading team in Singapore – the home of social trading. Follow the team on @SaxoStrats or post your comment below to engage with Saxo Bank's social trading platform. 

All material contained herein is provided for your general information. The information and commentaries are not intended to be and do not constitute financial advice, investment advice, trading advice or any other advice or recommendation of any sort offered or endorsed by Saxo Capital Markets Pte. Ltd. (“SCM SG”). Any expression of opinion (which may be subject to change without notice) is personal to the presenter and/or author; they do not reflect the view or opinion of SCM SG or its affiliates, neither do they constitute an endorsement of SCM SG’s view or analysis of the same.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. SCM SG does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment based on any commentaries or information provided here.
For further information, please click here.  

Saxo Capital Markets Pte Ltd ("Saxo Capital Markets") is a licensed subsidiary of Saxo Bank A/S, an online trading and investment specialist. Saxo Capital Markets serves as the APAC headquarters and holds a capital markets services licence under the Monetary Authority of Singapore; and a commodity broker licence issued by the International Enterprise Singapore. Clients can trade Forex, CFDs, Stocks, Futures, Options and other derivatives via SaxoWebTrader and SaxoTrader, the leading multi-asset online trading platforms.
Trading risks are magnified by leverage - losses can exceed your deposits. Trade only after you have acknowledged and accepted the risks. You should carefully consider whether trading in leveraged products is appropriate for you based on your financial circumstances. Please consider our Risk Warning and General Business Terms before trading with us. Please see full General Disclaimer.

Thousands of serious traders receive free news and analysis from Saxo Capital Markets each day. Saxo Capital Markets never sends these emails unsolicited; they are sent following acceptance of your membership and subscription request by Saxo Capital Markets at If you do not wish to receive any emails from Saxo Capital Markets in the future, please reply to this email with the word "UNSUBSCRIBE" in the subject header.

Copyright | Disclaimer | Risk Warning | Privacy Policy | Contact Us
Samsung Hub | 3 Church Street | # 30-01 | Singapore 049483
Company No. 200601141M


The Saxo Bank Group entities each provide execution-only service and access to permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on or as a result of the use of the Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. When trading through your contracting Saxo Bank Group entity will be the counterparty to any trading entered into by you. does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of ourtrading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws. Please read our disclaimers:
- Notification on Non-Independent Invetment Research
- Full disclaimer

Check your inbox for a mail from us to fully activate your profile. No mail? Have us re-send your verification mail